Stevanato Group S.p.A. (NYSE:STVN) Stock Holdings Decreased by Thornburg Investment Management Inc.

Key Points

• Thornburg Investment Management Inc. reduced its stake in Stevanato Group S.p.A. by 1.1%, owning 1,109,884 shares valued at approximately $22.66 million after selling 12,214 shares.
• Stevanato Group recently declared a dividend increase, raising its annual dividend to $0.0613 per share, reflecting a yield of 0.3%.
• Analysts have mixed ratings on Stevanato Group, with an average rating of "Moderate Buy" and a target price of €25.70 ($29.88), highlighting a general optimism about the stock's future performance.

Thornburg Investment Management Inc. lessened its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,109,884 shares of the company's stock after selling 12,214 shares during the period. Thornburg Investment Management Inc. owned about 0.37% of Stevanato Group worth $22,664,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Bessemer Group Inc. raised its stake in shares of Stevanato Group by 14,623.3% in the 1st quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock valued at $270,000 after acquiring an additional 13,161 shares during the period. Palisade Capital Management LP increased its stake in Stevanato Group by 52.0% during the 1st quarter. Palisade Capital Management LP now owns 91,431 shares of the company's stock worth $1,867,000 after buying an additional 31,283 shares during the period. D. E. Shaw & Co. Inc. purchased a new stake in Stevanato Group during the 4th quarter worth $281,000. Envestnet Asset Management Inc. increased its stake in Stevanato Group by 16.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company's stock worth $3,324,000 after buying an additional 23,545 shares during the period. Finally, Allianz SE purchased a new stake in Stevanato Group during the 4th quarter worth $748,000.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on STVN. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. Stephens raised shares of Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Stevanato Group currently has a consensus rating of "Moderate Buy" and an average price target of €25.70 ($29.88).

Stevanato Group Stock Up 1.7%

Shares of STVN traded up €0.43 ($0.50) during midday trading on Friday, hitting €25.14 ($29.23). The company had a trading volume of 551,500 shares, compared to its average volume of 337,123. The company's 50 day moving average price is €24.37 and its 200 day moving average price is €22.38. The stock has a market cap of $7.61 billion, a price-to-earnings ratio of 49.30, a PEG ratio of 2.48 and a beta of 0.55. Stevanato Group S.p.A. has a 52 week low of €17.12 ($19.91) and a 52 week high of €28.00 ($32.56). The company has a quick ratio of 1.26, a current ratio of 1.83 and a debt-to-equity ratio of 0.22.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.